Drug intelligence / Profile preview

Lipikar Baume AP+M + Lipikar Syndet

Development stage
Unknown
Lead developer
La Roche-Posay
Administration
Topical
01

Overview

Lipikar Baume AP+M + Lipikar Syndet is a complementary skincare regimen developed by La Roche-Posay (a brand of L'Oréal) specifically for the management of atopic eczema-prone, severely dry, and itchy skin. The regimen consists of two primary products: Lipikar Syndet AP+, a soap-free cream cleanser, and Lipikar Baume AP+M, a lipid-replenishing balm. These products are formulated with functional ingredients including Aqua Posae Filiformis (a postbiotic derived from thermal spring water), niacinamide, and shea butter. The regimen works by rebalancing the skin microbiome and restoring the epidermal moisture barrier. Clinical studies have demonstrated that daily use of this combination significantly reduces pruritus intensity, improves skin hydration, and enhances sleep quality and overall quality of life in patients ranging from newborns to adults. While marketed as cosmeceutical products rather than prescription pharmaceuticals, they are used as a therapeutic adjunct to standard atopic dermatitis treatments to prevent exacerbations and reduce relapse rates.

Brand names
Lipikar Syndet AP+
Other names
Lipikar Baume AP+M + Lipikar Syndet AP+La Roche-Posay Lipikar regimen

Beyond the preview

Go deeper on Lipikar Baume AP+M + Lipikar Syndet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipikar Baume AP+M + Lipikar Syndet.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call